AI assistant
Sending…
NANOVIRICIDES, INC. — Director's Dealing 2014
Sep 9, 2014
34915_dirs_2014-09-08_1858a104-d323-4133-959e-473c3eede227.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2014-09-05
Reporting Person: VYAS MEETA (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-08-25 | Common Stock, par value $0.001 | P | 21429 | $3.50 | Acquired | 147021 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-08-25 | Common Stock Warrants | $3.50 | X | 21429 | Disposed | 2014-08-15 | Common Stock (21429) | Indirect |
Footnotes
F1: Also includes 26,001 shares of common stock that are held in the name of Connect Capital Partners, LLC, of which Ms. Vyas holds voting and dispositive power. Does not include 192,860 shares of common stock underlying 38,572 shares of Series A Convertible Preferred Stock convertible into three and one half shares of Common Stock of the Common Stock solely upon a change in control of the Company or upon achieving certain trading prices.
More from NANOVIRICIDES, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Interim / Quarterly Report
2026
Feb 17
Regulatory Filings
2025
Dec 30
Regulatory Filings
2025
Dec 22
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Dec 15
Regulatory Filings
2025
Nov 26